Hidradenitis Suppurativa in Patients with Skin of Color: Emerging Therapies and Strategies for Effective Management
Hidradenitis suppurativa (HS) remains one of the most challenging chronic inflammatory diseases seen in dermatology. At the 2025 Skin Of Color Update conference in New York City, Dr. Tiffany Mayo led a case-based discussion on emerging therapies and management strategies for HS, with an emphasis on patients with skin of color.
HS affects between 0.1-4% of the population and is more common in …
Hidradenitis suppurativa (HS) remains one of the most challenging chronic inflammatory diseases seen in dermatology. At the 2025 Skin Of Color Update conference in New York City, Dr. Tiffany Mayo led a case-based discussion on emerging therapies and management strategies for HS, with an emphasis on patients with skin of color.
HS affects between 0.1-4% of the population and is more common in … 
In dermatology, mentorship extends far beyond career advice. At ODAC 2026, the Young Dermatology Leader Mentorship Program organized by Dermatology In-review and supported by Sun Pharma, highlighted the importance of mentorship and relationship-building early in one’s career. The program brought together five dermatology resident mentees with established leaders in the field to discuss and refle … 
Welcome to "JDD January 2026 Issue Highlights," your guided tour through this month's must-read studies, curated by the Journal of Drugs in Dermatology Editorial Team. This issue carries a Special Focus on Aesthetic Treatments, bringing together practical safety analyses, regulatory perspectives on regenerative medicine, advances in pigmentary and procedural care, and health‑equity research that … 
Mutations in which gene would likely be found in the neoplastic cells of this lesion?
A. PATCH
B. p53
C. Fumarate hydratase
D. CREBBP
E. p63
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
*Brand partners had no involvement in the content of the questions or answers. … 
Introduction
Pyoderma gangrenosum (PG) is a rare, neutrophilic dermatosis characterized by rapidly enlarging, painful ulcers with violaceous and undermined borders. It is commonly associated with systemic disorders, including rheumatoid arthritis, hematologic malignancies, and inflammatory bowel disease (IBD).¹ While PG often correlates with IBD flares, its pathogenesis is not well understood. C …